Cargando…
Reference standards for accurate validation and optimization of assays that determine integrated lentiviral vector copy number in transduced cells
Lentiviral vectors (LV) have emerged as a robust technology for therapeutic gene delivery into human cells as advanced medicinal products. As these products are increasingly commercialized, there are concomitant demands for their characterization to ensure safety, efficacy and consistency. Standards...
Autores principales: | Paugh, Barbara S., Baranyi, Lajos, Roy, Andre, He, Hua-Jun, Harris, Lindsay, Cole, Kenneth D., Artlip, Moria, Raimund, Caroline, Langan, Patricia S., Jana, Srikanta, Orentas, Rimas J., Lin-Gibson, Sheng, Krueger, Winfried, Dropulić, Boro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801692/ https://www.ncbi.nlm.nih.gov/pubmed/33431989 http://dx.doi.org/10.1038/s41598-020-79698-w |
Ejemplares similares
-
Advances in Lentiviral Vector-based Cell Therapy with Mesenchymal Stem Cells
por: Baranyi, Lajos, et al.
Publicado: (2012) -
A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy
por: Bari, Rafijul, et al.
Publicado: (2019) -
Corrigendum: A Distinct Subset of Highly Proliferative and Lentiviral Vector (LV)-Transducible NK Cells Define a Readily Engineered Subset for Adoptive Cellular Therapy
por: Bari, Rafijul, et al.
Publicado: (2019) -
A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines
por: Schneider, Dina, et al.
Publicado: (2017) -
Minimizing leukemia escape: implementing a dual anti-CD20- and CD19-scFv-based chimeric antigen receptor (CAR)
por: Schneider, Dina, et al.
Publicado: (2015)